Skip to content
← Back to this collection

PUBLICATIONS · 33601323

Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2021 Mar
First author
Pearson AD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Pearson AD
      type
      Author
    2. name
      DuBois SG
      type
      Author
    3. name
      Buenger V
      type
      Author
    4. name
      Kieran M
      type
      Author
    5. name
      Stegmaier K
      type
      Author
    6. name
      Bandopadhayay P
      type
      Author
    7. name
      Bennett K
      type
      Author
    8. name
      Bourdeaut F
      type
      Author
    9. name
      Brown PA
      type
      Author
    10. name
      Chesler L
      type
      Author
    11. name
      Clymer J
      type
      Author
    12. name
      Fox E
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Pearson AD
      type
      Author
    2. name
      DuBois SG
      type
      Author
    3. name
      Buenger V
      type
      Author
    4. name
      Kieran M
      type
      Author
    5. name
      Stegmaier K
      type
      Author
    6. name
      Bandopadhayay P
      type
      Author
    7. name
      Bennett K
      type
      Author
    8. name
      Bourdeaut F
      type
      Author
    9. name
      Brown PA
      type
      Author
    10. name
      Chesler L
      type
      Author
    11. name
      Clymer J
      type
      Author
    12. name
      Fox E
      type
      Author
    bibliography ids
    1. nci-bib-88fe8e3c5bcffebe96c794bd
    book metadata
    content sha256
    af3a8b3ee0e34ee9a9e93f2f55a8cab263eb5f1801ad9405429741adcc717bec
    document type
    citation
    dois
    1. 10.1016/j.ejca.2021.01.018
    electronic publication date
    display
    2021 Feb 16
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33601323
    immutable id
    pubmed:33601323@af3a8b3ee0e34ee9a9e93f2f55a8cab263eb5f1801ad9405429741adcc717bec
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    Source null
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    115-124
    volume
    146
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33601323
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      d1bac53f35b34790b7cd94daa5fc202f0ef6d848e83b1bc7942d4f7ea08223d1
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Mar
      precision
      month
      year
      2021
      publication types
      1. Consensus Statement
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      4. Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33601323/
      title
      Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.

      Preserved source evidence · Not medical advice